Moexipril

Moexipril
	File:Moexipril.png
Systematic (IUPAC) name
	(3S)-2-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid
Clinical data
Pregnancy; category	US: D (Evidence of risk) ; ;
Routes of; administration	Oral
Legal status
Legal status	UK: POM (Prescription only) ; US: ℞-only ;
Identifiers
CAS Number	103775-10-6
ATC code	C09AA13 (WHO)
PubChem	CID 91270
Chemical data
Formula	C27H34N2O7
Molar mass	498.568 g/mol[[Script error: No such module "String".]]
(verify)

Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Moexipril (marketed under the tradenames Univasc and Perdix^[1]) is an ACE inhibitor.^[2]

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />

30px	This drug article relating to the cardiovascular system is a stub. You can help ssf by expanding it. v d e

↑ Dart, Richard C. (2004). Medical toxicology. Lippincott Williams & Wilkins. p. 647. ISBN 9780781728454. Retrieved 2009-10-09.
↑ Hochadel, Maryanne, ed. (2006). The AARP Guide to Pills. Sterling Publishing Company. p. 640. ISBN 9781402717406. Retrieved 2009-10-09.